Trimopam is a dopamine receptor agonist of the benzazepine group. References: Breese GR, Criswell HE, Mueller RA. Evidence that lack of brain dopamine during development can increase the susceptibility for aggression and self-injurious behavior by influencing D1-dopamine receptor function. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14 Suppl:S65-80. Review. PubMed PMID: 1982973.

纯度：≥98%

CAS：20012-08-2